Literature DB >> 16973515

No significant differences in peritoneal fluid handling in children using PH-neutral or acidic solutions.

Peter Nourse1, Nicole C A J van de Kar, Hans L Willems, Cornelis H Schröder.   

Abstract

OBJECTIVES: Differences in peritoneal fluid handling in the acute setting can be expected if children are converted to pH-neutral dialysis solutions because conventional acidic solutions exert toxic effects on peritoneal mesothelial cells and microcirculation. Peritoneal fluid kinetics was therefore investigated with both types of solutions in a group of children.
DESIGN: Peritoneal equilibration tests (PETs) were performed in 12 patients [mean age 70 months, mean time on peritoneal dialysis (PD) 18 months] using a pH-neutral PD fluid (Physioneal 3.86%; Baxter Ltd, Castlebar, Ireland) and dextran 70 as a volume marker. The results of these PETs were compared to those of a historic group of 12 children (mean age 75 months, mean time on PD 17 months).
SETTING: Pediatric dialysis unit in a tertiary institute. PATIENTS: Stable pediatric PD patients. MAIN OUTCOME MEASURES: Transcapillary ultrafiltration (TCUF) and marker clearance, dialysate-to-plasma (D/P) ratios for urea and creatinine, and D(t)/D(0) ratio for glucose.
RESULTS: TCUF and lymphatic absorption were not different between the two groups. There was also no significant difference in small solute clearance measured by D/P ratio for urea and creatinine and D(t)/D(0) ratio for glucose.
CONCLUSION: Peritoneal fluid kinetics is not significantly altered if pH-neutral dialysis solutions are applied compared to acidic solutions. An altered TCUF, as is hypothetically possible using an acidic solution, was not established.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973515

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  1 in total

1.  Reducing perceived pain levels during nonbreast lymphoscintigraphy.

Authors:  Mickaila J Johnston; James A Ntambi; Nicki Hilliard; Horace J Spencer; Rita Vaughn; Shawna S Owens; Rebecca S Myrick; Larry D Parker; Douglas A Garner; Tracy L Yarbrough
Journal:  Clin Nucl Med       Date:  2015-12       Impact factor: 7.794

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.